Financial Summary (All financials)
In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 336.8 | 297.7 | 224.4 | 167.5 | 126.0 | 71.1 |
Revenue growth | 13.2% | 32.6% | 33.9% | 33.0% | 77.1% | |
Cost of goods sold | 79.2 | 67.9 | 58.6 | 48.4 | 33.1 | 21.9 |
Gross profit | 257.6 | 229.8 | 165.8 | 119.1 | 92.8 | 49.2 |
Gross margin | 76.5% | 77.2% | 73.9% | 71.1% | 73.7% | 69.2% |
Sales and marketing | 213.0 | 183.9 | 144.4 | 119.1 | 70.3 | 56.4 |
Research and development | 82.8 | 61.7 | 47.4 | 31.5 | 17.8 | 12.3 |
General and administrative | 63.0 | 57.7 | 51.2 | 30.7 | 22.9 | 21.1 |
EBITA | -97.9 | -73.0 | -77.2 | -62.1 | -18.1 | -40.5 |
EBITA margin | -29.1% | -24.5% | -34.4% | -37.1% | -14.4% | -57.0% |
Amortization of intangibles | 3.3 | 0.5 | | | | |
EBIT | -101.2 | -73.5 | -77.2 | -62.1 | -18.1 | -40.5 |
EBIT margin | -30.1% | -24.7% | -34.4% | -37.1% | -14.4% | -57.0% |
Pre-tax income | -99.8 | -71.9 | -78.9 | -64.2 | -26.9 | -43.4 |
Income taxes | 18.7 | 2.9 | 1.8 | 1.3 | 0.3 | 0.6 |
Net income | -118.5 | -74.8 | -93.5 | -65.5 | -27.3 | -2.2 |
Net margin | -35.2% | -25.1% | -41.7% | -39.1% | -21.6% | -3.1% |
|
Diluted EPS | ($2.58) | ($1.83) | ($8.20) | ($11.67) | ($6.61) | ($0.91) |
Shares outstanding (diluted) | 46.0 | 41.0 | 11.4 | 5.6 | 4.1 | 2.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|